Clinical Trials Browser

Neoplasm, Residual × Lenalidomide × Lymphoid × Clear all

NCT03863184 2026-04-28

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL

Phase 2 Active not recruiting

37 enrolled 9 charts

Neoplasm, Residual, Lymphoma, Mantle-Cell

NCT06414148 2025-06-05

EpLCART

Phase 2 Recruiting

Lymphoma, Recurrence, Neoplasm, Residual